Your browser doesn't support javascript.
loading
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo.
Bei, Roberto; Benvenuto, Monica; Focaccetti, Chiara; Fazi, Sara; Moretti, Marta; Nardozi, Daniela; Angiolini, Valentina; Ciuffa, Sara; Cifaldi, Loredana; Carrano, Raffaele; Palumbo, Camilla; Miele, Martino Tony; Bei, Riccardo; Barillari, Giovanni; Manzari, Vittorio; De Smaele, Enrico; Modesti, Andrea; Masuelli, Laura.
Afiliação
  • Bei R; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy. bei@med.uniroma2.it.
  • Benvenuto M; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
  • Focaccetti C; Saint Camillus International University of Health and Medical Sciences, via di Sant'Alessandro 8, 00131, Rome, Italy.
  • Fazi S; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
  • Moretti M; Department of Experimental Medicine, University of Rome "Sapienza", viale Regina Elena 324, 00161, Rome, Italy.
  • Nardozi D; Department of Experimental Medicine, University of Rome "Sapienza", viale Regina Elena 324, 00161, Rome, Italy.
  • Angiolini V; Department of Experimental Medicine, University of Rome "Sapienza", viale Regina Elena 324, 00161, Rome, Italy.
  • Ciuffa S; Department of Experimental Medicine, University of Rome "Sapienza", viale Regina Elena 324, 00161, Rome, Italy.
  • Cifaldi L; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
  • Carrano R; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
  • Palumbo C; Academic Department of Pediatrics (DPUO), Ospedale Pediatrico Bambino Gesù, IRCCS, 00165, Rome, Italy.
  • Miele MT; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
  • Bei R; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
  • Barillari G; Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy.
  • Manzari V; Medical School, University of Rome "Tor Vergata", 00133, Rome, Italy.
  • De Smaele E; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
  • Modesti A; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
  • Masuelli L; Department of Experimental Medicine, University of Rome "Sapienza", viale Regina Elena 324, 00161, Rome, Italy.
J Transl Med ; 20(1): 286, 2022 06 25.
Article em En | MEDLINE | ID: mdl-35752861
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores ErbB / Mesotelioma Maligno Limite: Animals / Humans Idioma: En Revista: J Transl Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores ErbB / Mesotelioma Maligno Limite: Animals / Humans Idioma: En Revista: J Transl Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália